Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion-Reference-Cited by-同舟云学术

Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion

Published:2018-02 Issue:2 Volume:7 Page:181-191
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:Journal of Comparative Effectiveness Research

Author:

Law Ernest¹,Harrington Rachel¹,Alexander G Caleb²³⁴,Saha Soumi⁵,Oehrlein Elisabeth⁶,Perfetto Eleanor M⁶⁷

Affiliation:

1. Department of Pharmacy Systems, Outcomes & Policy, University of Illinois at Chicago, Chicago, IL 60612, USA

2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA

3. Center for Drug Safety & Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA

4. Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD 21205, USA

5. Academy of Managed Care Pharmacy, Alexandria, VA 22314, USA

6. Department of Pharmaceutical Heath Services Research, University of Maryland, Baltimore, MD 21201, USA

7. National Health Council, Washington, DC 20036, USA

Abstract

The goal of comparative effectiveness research (CER) and patient-centered outcomes research (PCOR) is to improve health outcomes by providing stakeholders with evidence directly relevant to decision making. In January 2017, the Pharmaceutical Research and Manufacturers Association Foundation, alongside the Academy for Managed Care Pharmacy, organized a conference aimed at engaging experts and opinion leaders representing clinicians, patients and payers to identify and discuss barriers and strategies to enhancing uptake and use of CER/PCOR. This report summarizes the conference discussion in the following sections: preconference survey; summary of barriers and strategies to the uptake of CER/PCOR identified by conference attendees; and future perspectives on the field.

Publisher

Future Medicine Ltd

Subject

Health Policy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/cer-2017-0060

Reference25 articles.

1. Comparative-Effectiveness Research — Implications of the Federal Coordinating Council's Report

2. Comparative Effectiveness Research: A Report From the Institute of Medicine

3. The Patient-Centered Outcomes Research Institute (PCORI) National Priorities for Research and Initial Research Agenda

4. How does PCOR relate to comparative effectiveness research (CER) and does PCORI fund CER? PCORI help center. https://help.pcori.org/hc/en-us/articles/213717137-How-does-PCOR-relate-to-comparative-effectiveness-research-CER-and-does-PCORI-fund-CER

5. Clinical Research to Clinical Practice — Lost in Translation?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Q-TWiST analysis of survival benefits with brigatinib versus crizotinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer based on results of the ALTA-1L trial;Lung Cancer;2023-11

2. Bridging the gap: Identifying diverse stakeholder needs and barriers to accessing evidence and resources for children’s pain;Canadian Journal of Pain;2022-05-17

3. Value-based evidence across health care sectors: a push for transparent real-world studies, data, and evidence dissemination;Health Economics, Policy and Law;2022-04-06

4. Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group;Value in Health;2020-06

5. Factors associated with evidence-based decision-making among patients and providers;Journal of Comparative Effectiveness Research;2019-07